Literature DB >> 15459650

Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis.

Mehmet Tanyuksel1, Cakir Guney, Engin Araz, M Ali Saracli, Levent Doganci.   

Abstract

Toxoplasmosis has been well known as an important human infection to consider especially in pregnant women. Although many serologic methods are available, the diagnosis of toxoplasmosis can be extremely difficult. The presence of increased levels of Toxoplasma-specific IgG antibodies indicates an infection, but it does not differentiate between a recent and past infection. The purpose of our study was to compare the performance of the ELISA T. gondii IgG/IgM test, a widely used enzyme-linked immunosorbent assay, to the ELISA IgG avidity method. One hundred and four serum samples (from 38 males and 66 females) were tested and evaluated from symptomatic patients (chorioretinitis, lymphadenopathy), and from women in their first trimester of pregnancy who were suspected of having toxoplasmosis. The high IgG avidity and ELISA IgG antibody levels were in agreement for 51 of the specimens (49.0%). Thirty-eight discrepant (borderline) results from the IgG avidity method were positive for IgM (3 specimens) and IgG (37 specimens). Interestingly, out of the eight serum samples that were positive for both IgG and IgM antibodies, two samples were low IgG avidity, and three samples were borderline. There was no statistically significant relation observed between the results of the IgG avidity method and the ELISA IgG test, and the IgG avidity method and ELISA IgM test (chi2 = 1.987; p = 0.370 and chi2 = 2.152; p = 0.341, respectively). The IgG avidity method was considered easy to perform and an acceptable approach for the differentiation of discrepant results (recent/chronic) and for the current detection of T. gondii antibodies. We concluded that the determination of IgG avidity is a helpful tool for the diagnosis of the ocular form of toxoplasmosis and it is a safe method for screening this disease in the first trimester of pregnancy. Copyright 2004 The Microbiological Society of Korea

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459650

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  5 in total

1.  Modification and Evaluation of Avidity IgG Testing for Differentiating of Toxoplasma gondii Infection in Early Stage of Pregnancy.

Authors:  Mohammad Reza Bonyadi; Parvin Bastani
Journal:  Cell J       Date:  2013-08-24       Impact factor: 2.479

2.  The necessity of confirmatory testing in serodiagnosis of toxoplasmosis in iran.

Authors:  Mehrzad Saraei; Seyedeh Zeinab Fattahi; Mojtaba Shahnazi; Afshin Afshari; Safar Ali Alizadeh; Hassan Jahanihashemi
Journal:  Iran J Parasitol       Date:  2013-10       Impact factor: 1.012

3.  Seroepidemiological analysis of toxoplasmosis in college students.

Authors:  Jaqueline Polizeli Rodrigues; Fernando Frei; Italmar Teodorico Navarro; Luciana Pereira Silva; Monica Yonashiro Marcelino; Heitor Franco de Andrade-Junior; Carolina Arruda de Faria; Marislene Santos; João Tadeu Ribeiro-Paes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-01-05

4.  Serological Evaluation of Anti-Toxoplasma gondii Antibodies in Patients with Acute Leukemia and Lymphoma through Chemotherapy.

Authors:  Fatemeh Tabatabaie; Taher Elmi; Majid Khanmohammadi; Lame Akhlaghi; Mahmoud Mahami-Oskouei; Mehdi Arshadi
Journal:  Iran J Parasitol       Date:  2020 Apr-Jun       Impact factor: 1.012

5.  Prevalence and Risk Factors of Toxoplasma gondii Infection among Pregnant Women in Hormozgan Province, South of Iran.

Authors:  Seyedeh Zahra Khademi; Fatemeh Ghaffarifar; Abdolhossein Dalimi; Parivash Davoodian; Amir Abdoli
Journal:  Iran J Parasitol       Date:  2019 Jan-Mar       Impact factor: 1.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.